All currency values in $ millions unless otherwise noted
Scroll
| Income Statement | TTM | APR 2023 ~338.6:1 split | APR 2022 12:1 split | APR 2021 ~61.8:1 split | APR 2020 | APR 2019 7:1 split |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenue | $0 | – | – | – | – | $0 |
| Cost of Revenue | – | – | – | – | – | $0 |
| Gross Profit | – | – | – | -$0 | $0 | $0 |
| General & Administrative | – | – | – | – | – | $0 |
| Provision for Doubtful Accounts | -$0 | – | – | $0 | -$0 | $0 |
| Total Operating Expenses | $0 | $3 | $4 | $3 | $0 | $0 |
| Operating Income | -$0 | -$2 | -$3 | -$3 | -$0 | -$0 |
| Non-Operating | ||||||
| Net Interest Expense | -$0 | -$0 | $0 | -$0 | -$0 | -$0 |
| Other Non-Operating Income (Expense) | -$1 | -$0 | -$0 | $0 | -$1 | -$0 |
| EBT (Earnings Before Tax) | – | -$2 | -$3 | -$3 | -$2 | -$1 |
| Income Tax Expense | – | $0 | $0 | $0 | $0 | $0 |
| Net Income | ||||||
| Net Income | -$1 | -$2 | -$3 | $0 | -$2 | -$1 |
| Per Share Data | ||||||
| Revenue Per Share | $0.01 | – | – | – | – | $0.00 |
| EPS (Basic) | -$123.82 | -$0.00 | -$0.76 | $0.00 | -$256.86 | -$1.32 |
| EPS (Diluted) | -$160.00 | -$0.00 | -$0.76 | $0.00 | -$257.50 | -$132.50 |
| Weighted Avg Shares (Basic) | 51.0M | – | 1.14B | 94.8M | 1.5M | 101.8M |
| Weighted Avg Shares (Diluted) | 51.0M | – | 1.14B | 94.8M | 1.5M | 101.8M |
| Shares Outstanding | 203,994.68 | 1.54B | 4.6M | 379,155.328 | 6,133.264 | 407,251.236 |
Verde Bio Holdings (APHD) financials: revenue, profit and margins
Verde Bio Holdings (APHD) generated about n/a in revenue and -$3 million in net income over the trailing twelve months, growing at roughly 127.4% a year. Figures are from SEC filings; this is analysis, not investment advice.
Frequently asked
Is Verde Bio Holdings profitable?+
Verde Bio Holdings reported about -$3 million in net loss over the trailing twelve months. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.
How fast is Verde Bio Holdings growing?+
Verde Bio Holdings's revenue has compounded at roughly 127.4% a year over the past five years. Growth only creates value when it is profitable and cash-generative, so read this rate alongside APHD's margins and free cash flow. This is analysis from SEC filings, not investment advice.
SourceFinancial statements computed from the 10-Q filed 15 Mar 2024, covering the period ending 31 Jan 2024, as reported to the SEC. Data last refreshed 12 Oct 2026. How this is calculated.
Fiscal year ends Apr.
Peers
Crude Petroleum & Natural Gas · Pick stocks to compare with APHD
Spot a number that looks wrong? Check it in APHD's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing APHD
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.